Symbol="TCBP"
AssetType="Common Stock"
Name="TC BioPharm Holdings PLC"
Description="TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, is focused on developing immunotherapy products based on its gamma delta allogeneic T-cell platform. The company is headquartered in Motherwell, the United Kingdom."
CIK="1872812"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, GB"
FiscalYearEnd="December"
LatestQuarter="2022-06-30"
MarketCapitalization="2213000"
EBITDA="-11158647"
PERatio="None"
PEGRatio="None"
BookValue="-0.027"
DividendPerShare="0"
DividendYield="0"
EPS="-2.65"
RevenuePerShareTTM="5.59"
ProfitMargin="-0.361"
OperatingMarginTTM="-3.101"
ReturnOnAssetsTTM="-0.785"
ReturnOnEquityTTM="0"
RevenueTTM="3844500"
GrossProfitTTM="3844500"
DilutedEPSTTM="-2.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.886"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="84.97"
PriceToBookRatio="137.08"
EVToRevenue="84.78"
EVToEBITDA="-85.23"
Beta="None"
num_52WeekHigh="22"
num_52WeekLow="0.418"
num_50DayMovingAverage="0.634"
num_200DayMovingAverage="3.833"
SharesOutstanding="4688500"
DividendDate="None"
ExDividendDate="None"
symbol="TCBP"
open="0.48"
high="0.57"
low="0.48"
price="0.50"
volume="870318.00"
latest_trading_day="2023-07-27"
previous_close="0.47"
change="0.03"
change_percent="5.9958%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="88"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="12"
Volume_recent_avg="464647"
Change_recent_avg="-0.03"
Delta_recent_avg="0.19"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-2.55"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="12"
Aroon_momentum_negative="88"
image_negative_thumbnail_id_1="121"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_negative_thumbnail_id_2="506"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0099.jpeg"
image_neutral_thumbnail_id_1="540"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="665"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0043.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
